Jon-Kar Zubieta

6.0k total citations · 3 hit papers
49 papers, 4.5k citations indexed

About

Jon-Kar Zubieta is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Jon-Kar Zubieta has authored 49 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 19 papers in Cognitive Neuroscience and 18 papers in Physiology. Recurrent topics in Jon-Kar Zubieta's work include Pain Mechanisms and Treatments (16 papers), Pain Management and Placebo Effect (13 papers) and Neuropeptides and Animal Physiology (10 papers). Jon-Kar Zubieta is often cited by papers focused on Pain Mechanisms and Treatments (16 papers), Pain Management and Placebo Effect (13 papers) and Neuropeptides and Animal Physiology (10 papers). Jon-Kar Zubieta collaborates with scholars based in United States, Australia and Brazil. Jon-Kar Zubieta's co-authors include Christian S. Stohler, Tor D. Wager, Yolanda R. Smith, Robert A. Koeppe, Joshua A. Bueller, Yanjun Xu, David Scott, David Goldman, Mary M. Heitzeg and Fabrizio Benedetti and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Jon-Kar Zubieta

48 papers receiving 4.3k citations

Hit Papers

COMT val 158 met Genotype Affects µ-Opioid Neurotransmi... 2001 2026 2009 2017 2003 2001 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon-Kar Zubieta United States 25 1.9k 1.5k 1.0k 835 752 49 4.5k
Joshua A. Bueller United States 21 1.9k 1.0× 1.9k 1.2× 891 0.9× 749 0.9× 819 1.1× 27 4.8k
Igor Elman United States 40 1.8k 0.9× 1.2k 0.8× 1.7k 1.6× 1.4k 1.7× 1.1k 1.5× 141 5.7k
David Scott United States 23 2.1k 1.1× 1.5k 1.0× 592 0.6× 922 1.1× 689 0.9× 53 3.9k
Ruth Ruscheweyh Germany 33 947 0.5× 2.2k 1.4× 1.0k 1.0× 1.2k 1.4× 875 1.2× 130 4.5k
Paul Geha United States 23 1.9k 1.0× 2.2k 1.4× 596 0.6× 700 0.8× 1.7k 2.2× 40 4.3k
Marta Čeko United States 22 1.2k 0.7× 1.3k 0.9× 386 0.4× 735 0.9× 918 1.2× 35 3.1k
B. Laurent France 23 2.1k 1.1× 3.5k 2.3× 484 0.5× 1.0k 1.2× 1.2k 1.6× 64 5.7k
Clas Linnman United States 31 1.6k 0.9× 675 0.4× 430 0.4× 789 0.9× 450 0.6× 65 3.6k
Eric R. Braverman United States 31 839 0.4× 680 0.4× 1.5k 1.5× 1.3k 1.5× 592 0.8× 117 4.2k
S. Craig Risch United States 38 1.2k 0.6× 354 0.2× 853 0.8× 1.2k 1.5× 692 0.9× 132 4.7k

Countries citing papers authored by Jon-Kar Zubieta

Since Specialization
Citations

This map shows the geographic impact of Jon-Kar Zubieta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon-Kar Zubieta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon-Kar Zubieta more than expected).

Fields of papers citing papers by Jon-Kar Zubieta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon-Kar Zubieta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon-Kar Zubieta. The network helps show where Jon-Kar Zubieta may publish in the future.

Co-authorship network of co-authors of Jon-Kar Zubieta

This figure shows the co-authorship network connecting the top 25 collaborators of Jon-Kar Zubieta. A scholar is included among the top collaborators of Jon-Kar Zubieta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon-Kar Zubieta. Jon-Kar Zubieta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DaSilva, Alexandre F., Dajung J. Kim, Manyoel Lim, et al.. (2023). Effect of High-Definition Transcranial Direct Current Stimulation on Headache Severity and Central μ-Opioid Receptor Availability in Episodic Migraine. Journal of Pain Research. Volume 16. 2509–2523. 4 indexed citations
2.
Kim, Dajung J., Thiago D. Nascimento, Manyoel Lim, et al.. (2023). Exploring HD-tDCS Effect on μ-opioid Receptor and Pain Sensitivity in Temporomandibular Disorder: A Pilot Randomized Clinical Trial Study. Journal of Pain. 25(4). 1070–1081. 3 indexed citations
3.
Love, Tiffany, Andrey A. Shabalin, Rachel L. Kember, et al.. (2022). Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function. Neuropsychopharmacology. 47(10). 1784–1790. 2 indexed citations
4.
Baker, Anne, et al.. (2022). Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation. Translational Psychiatry. 12(1). 20–20. 9 indexed citations
5.
Baker, Anne, Vincent Koppelmans, Brian J. Mickey, et al.. (2022). Altered Reward Processing and Sex Differences in Chronic Pain. Frontiers in Neuroscience. 16. 889849–889849. 9 indexed citations
6.
Prossin, Alan R., Alisa E. Koch, Phillip L. Campbell, et al.. (2021). Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission. Molecular Psychiatry. 27(2). 831–839. 8 indexed citations
7.
Garland, Eric L., Rachel Atchley, Adam W. Hanley, Jon-Kar Zubieta, & Brett Froeliger. (2019). Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Science Advances. 5(10). eaax1569–eaax1569. 70 indexed citations
8.
Nascimento, Thiago D., Niko Kaciroti, Marcos F. DosSantos, et al.. (2019). Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. NeuroImage Clinical. 23. 101905–101905. 22 indexed citations
9.
DelDonno, Sophie R., Brian J. Mickey, Patrick Pruitt, et al.. (2019). Influence of childhood adversity, approach motivation traits, and depression on individual differences in brain activation during reward anticipation. Biological Psychology. 146. 107709–107709. 18 indexed citations
10.
Peciña, Marta, Jordan F. Karp, Sanjay J. Mathew, et al.. (2018). Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches. Molecular Psychiatry. 24(4). 576–587. 135 indexed citations
11.
Peciña, Marta, Magdalena Sikora, Erich T. Avery, et al.. (2017). Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response. European Neuropsychopharmacology. 27(10). 977–986. 76 indexed citations
12.
Peciña, Marta, Christian S. Stohler, & Jon-Kar Zubieta. (2013). Neurobiology of placebo effects: expectations or learning?. Social Cognitive and Affective Neuroscience. 9(7). 1013–1021. 42 indexed citations
13.
Falcone, Mary, Allison Gold, E. Paul Wileyto, et al.. (2012). μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology. 222(4). 701–708. 6 indexed citations
14.
Elman, Igor, Jon-Kar Zubieta, & David Borsook. (2011). The Missing P in Psychiatric Training. Archives of General Psychiatry. 68(1). 12–12. 94 indexed citations
15.
Ray, Riju, Kosha Ruparel, Andrew B. Newberg, et al.. (2011). Human Mu Opioid Receptor ( OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of Sciences. 108(22). 9268–9273. 110 indexed citations
16.
Stohler, Christian S. & Jon-Kar Zubieta. (2010). Pain Imaging in the Emerging Era of Molecular Medicine. Methods in molecular biology. 617. 517–537. 7 indexed citations
17.
Wager, Tor D., David Scott, & Jon-Kar Zubieta. (2007). Placebo effects on human μ-opioid activity during pain. Proceedings of the National Academy of Sciences. 104(26). 11056–11061. 425 indexed citations
18.
Benedetti, Fabrizio, Helen S. Mayberg, Tor D. Wager, Christian S. Stohler, & Jon-Kar Zubieta. (2005). Neurobiological Mechanisms of the Placebo Effect. Journal of Neuroscience. 25(45). 10390–10402. 508 indexed citations breakdown →
19.
Zubieta, Jon-Kar, Wai‐Ying Wendy Yau, David Scott, & Christian S. Stohler. (2005). Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain Behavior and Immunity. 20(1). 15–26. 85 indexed citations
20.
Meltzer, C C, Jon-Kar Zubieta, Jason Brandt, et al.. (1996). Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology. 47(2). 454–461. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026